Sign In
Get Clay Free →

Suggestions

    Daniel van den Bergh

    Senior Investment Director, Endeavour Vision

    Daniel van den Bergh is a healthcare technology investor at Kaiser Permanente Ventures with a rich background in investment, strategy, and healthcare management.

    Daniel holds an MBA in Health Care Management & Entrepreneurial Management from the University of Pennsylvania - The Wharton School and a BS in Biological Engineering & Applied Economics from Cornell University.

    Prior to his current role, he served as the Senior Investment Director at Endeavour Vision and had various positions at Kaiser Permanente Ventures, including Director, Principal, Senior Associate, and Board Director.

    Daniel van den Bergh also held roles such as Board Observer at NOCD and Ordr Inc., Board Director at Nuvolo, Protenus, and Validic, Board Observer at Talix, and various other key positions in different organizations within the healthcare and investment sectors.

    His extensive experience includes strategic roles at Lumiata as Director of Strategy & Operations and Head of Projects, as well as roles in venture capital and M&A at EC Mergers & Acquisitions, Safeguard Scientifics, and Citigroup Global Markets.

    With his strong educational foundation and diverse experience across multiple organizations, Daniel van den Bergh is a seasoned professional in healthcare technology investment and management.

    Highlights

    Sep 21 · Business Wire
    NOCD Raises $33 Million to Address Global OCD Crisis; Series B Financing to Support People Struggling with OCD, Fuel Growth - Business Wire
    Sep 21 · Yahoo Finance
    NOCD Raises $33 Million to Address Global OCD Crisis; Series B Financing to Support People Struggling with OCD, Fuel Growth - Yahoo Finance
    Daniel van den Bergh
    Add to my network

    Location

    San Francisco Bay Area